年龄而非反复暴露于钆特酸葡胺与儿科患者深部脑核团T1和T2加权信号强度变化相关
该回顾性双队列研究评估了反复暴露于钆特酸葡胺对儿科患者深部脑核团T1和T2加权信号强度的影响,并分析了年龄相关的信号变化。结果显示,钆特酸葡胺给药次数对任何感兴趣区的信号强度增加均无影响,而年龄与多个深部脑核团的信号强度变化显著相关。
要点
- 反复暴露于钆特酸葡胺与儿科患者脑深部核团高信号无关。
- 年龄与T1加权苍白球和尾状核信号增高、T2加权苍白球和齿状核信号减低相关。
- 在无钆暴露的对照组中同样观察到年龄相关的信号变化,提示脑成熟过程的影响。
核心结论
- 反复暴露于钆特酸葡胺与儿科患者脑高信号无关,而年龄对多个深部脑核团的信号强度变化有重要贡献。
研究设计与样本
- 回顾性双队列研究;纵向研究纳入24例接受至少10次钆特酸葡胺的儿科患者(0.7-16.4岁,M=5.74,SD=4.15),对照组为190例无钆暴露者(1-20岁,每岁10例);测量12个深部脑核团的T1加权梯度回波和T2加权快速自旋回波信号强度,以脑桥归一化,采用混合效应模型分析。
诊断标准与关键数值
- 钆特酸葡胺给药次数对任何感兴趣区的信号强度增加均无影响(所有P>0.05)。
- 在暴露组中,年龄与T1加权苍白球信号增加显著相关(P<0.01),与T1加权尾状核信号增加显著相关(P<0.05),与T2加权苍白球信号减低显著相关(P<0.001),与T2加权齿状核信号减低显著相关(P<0.005)。
- 在无钆暴露对照组中,多个感兴趣区(包括苍白球和尾状核)显示年龄依赖的T1加权信号增加,以及T2加权苍白球和齿状核信号减低(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Current findings on gadolinium deposition in the pediatric brain due to repeated exposure to macrocyclic contrast agents are inconclusive and possibly confounded by brain maturation processes. We evaluated the longitudinal effects of repeated gadoterate meglumine exposure (Dotarem; Guerbet, Villepinte, France) on the T1- and T2-weighted signal intensity (SI) in pediatric patients, and assessed the magnitude of age-related increase in T1-weighted (and decrease in T2-weighted) SI in a control cohort without prior gadolinium exposure.
MATERIALS AND METHODS: In this retrospective, double-cohort study, magnetic resonance imaging (MRI) data of 24 patients (0.7-16.4 years, M = 5.74, SD = 4.15) who received at least 10 doses of exclusively gadoterate meglumine were included in the longitudinal study. The MRI data of 190 controls (age range, 1-20 years; 10 patients/bin; bin width, 1 year) without any prior gadolinium-based contrast exposure were included in the control, cross-sectional study to assess the age-dependent SI changes in the regions of interest (ROIs). We measured SI (native), T1-weighted gradient echo, and T2-weighted fast spin-echo of 12 deep brain nuclei. The ROIs were measured at each of the first 11 MRI examinations of the contrast-exposed patients and in the control subject's MRI. Regions of interest's SIs, normalized by the pons, were analyzed with mixed effects models, accounting for the potential confounding factors, such as radiotherapy and chemotherapy.
RESULTS: The number of gadoterate meglumine administrations had no effect on the SI increase in any of the ROIs (all P > 0.05), but age significantly correlated with increased SI in T1-weighted globus pallidus (GP; P < 0.01) and caudate (P < 0.05), and with decreased SI in T2-weighted GP (P < 0.001) and dentate nucleus (P < 0.005) in the contrast-exposed group. The cross-sectional analyses of the control cohort showed a significant age-dependent T1-weighted SI increase in multiple ROIs, including the GP and caudate, and decrease in the T2-weighted GP and dentate nucleus (P < 0.05).
CONCLUSIONS: Repeated exposure to gadoterate meglumine was not associated with brain hyperintensity in the pediatric patients, whereas age importantly contributed to the SI changes in several deep brain nuclei.
引用
- Pozeg P, Forget J, Meuli RA, et al. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients. Invest Radiol. 2019. PMID: 30973458. doi:10.1097/RLI.0000000000000564
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。